Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts
Table 1
Patients’ demographic, clinical data, and preoperative medication.
Study groups
CTRL ()
CHD ()
CHD-DM ()
Demographics
Age
Sex, M/F (male/female)
15/10
26/4
16/4
Clinical characteristics
BMI
Cholesterol (mg/dL)
FPG
LVEF
HT
15 (60)
30 (100)
20 (100)
AF
3 (12)
2 (6.67)
0
Preoperative medication
Aspirin
5 (20)
30 (100)
20 (100)
-blockers
20 (80)
30 (100)
20 (100)
Anticoagulants
25 (100)
30 (100)
20 (100)
Statins
18 (72)
30 (100)
20 (100)
Nitrates
8 (32)
21 (70)
15 (75)
Calcium channel blockers
5 (20)
8 (26.67)
7 (35)
ACE inhibitors
0
30 (100)
20 (100)
Diuretics
25 (100)
30 (100)
20 (100)
Insulin
0
0
5 (25)
Oral antidiabetics
0
0
20 (75)
Antibiotherapy
25 (100)
30 (100)
20 (100)
Data are means SEM. In parentheses the percentages of the corresponding variable are mentioned. versus CTRL; : CHD versus CHD-DM. BMI: body mass index, FPG: fasting plasma glucose, LVEF: left ventricular ejection fraction, HT: hypertension, AF: atrial fibrillation, and ACEI: angiotensin-converting-enzyme inhibitors.
